Skip to main content
Skip to main content
ARGC logo

Arion Group Corp. (ARGC)

$2.50 +$0.00 (+0.00%) |CouncilHOLD · 45 · C
Bottom line: HOLD — our Council read (45/100) and AI Score (45/100) broadly agree.
MCap: $19.07M| P/E Ratio: -232.8| Vol: 100| 52-wk range: $2.50 – $2.50
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Arion Group Corp. (ARGC) trades at $2.50 with AI Score 45/100 (Grade C). Arion Group Corp. is engaged in the manufacturing and distribution of dietary ingredients and nutritional supplements across the United States. Market cap: $19.07M, Sector: Financial services.

Price live · AI analysis from Jun 13, 2026
Arion Group Corp. is engaged in the manufacturing and distribution of dietary ingredients and nutritional supplements across the United States. Additionally, the company provides specialized consulting services for third parties in the planning, design, and compliance aspects of cannabis cultivation.

Analyst Coverage for ARGC: ARGC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ARGC against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
HOLD 45/100 · C

ARGC: the 1 perspectives are evenly split.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

Arion Group Corp. (ARGC) Financial Services Profile

CEOJay Hamilton
HeadquartersCity Of Industry, US
IPO Year2018

Arion Group Corp., incorporated in 2016 and based in City of Industry, California, operates a dual business model focusing on the manufacturing and distribution of dietary ingredients and nutritional supplements in the U.S. Concurrently, it offers consulting services for cannabis cultivation, encompassing planning, design, and compliance for third-party clients.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Jun 13, 2026

What Is the Investment Thesis for ARGC?

Arion Group Corp. presents an investment profile characterized by its unique dual business model, encompassing both the dietary ingredient/nutritional supplement market and cannabis cultivation consulting. While the company reported a significant negative profit margin of -393.5%, it maintains a positive gross margin of 38.9%, indicating efficiency in its core manufacturing and distribution activities before operating expenses. The company's market capitalization stands at $0.02 billion, reflecting its status as a micro-cap entity. The negative beta of -0.14 suggests a low correlation with broader market movements, potentially offering diversification benefits, though this can also imply idiosyncratic risk. Growth catalysts include the expanding U.S. market for nutritional supplements and the ongoing legalization and maturation of the cannabis industry, which could drive demand for its specialized consulting services. However, the 'Medium Risk' AI insight and the inherent challenges of operating with a substantial negative profit margin necessitate careful consideration of operational efficiencies and revenue scaling. The company's OTC listing also introduces specific liquidity and disclosure risks.

Based on FMP financials and quantitative analysis

ARGC Key Highlights

  • Arion Group Corp. maintains a gross margin of 38.9%, indicating profitability at the core operational level before accounting for operating expenses.
  • The company reported a profit margin of -393.5%, highlighting significant operational or non-operating losses relative to its revenue.
  • With a market capitalization of $19.07M, Arion Group Corp. is classified as a micro-cap company, often associated with higher volatility and lower liquidity.
  • The company's stock exhibits a Beta of -0.14, suggesting a low or inverse correlation with the overall market, which can be atypical for most operating businesses.
  • Arion Group Corp. does not currently pay a dividend, consistent with many growth-focused or smaller capitalization companies.

Who Are ARGC's Competitors?

ARGC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
NSH NavSight Holdings, Inc. $9.93 +3.01% 69
LRGR Luminar Media Group, Inc. $0.50 +47.06% $22.39M 68
LMAOU LMF Acquisition Opportunities, Inc. $12.46 +41.59% 68
APXTW Apex Treasury Corporation $0.37 +5.11% $1.96B 66
DGNR Dragoneer Growth Opportunities Corp. $9.26 +0.00% $5.79B 57
KWM K Wave Media Ltd. $0.15 -2.40% $10.04M 57
IOAC Innovative International Acquisition Corp. $9.60 -14.44% $100.74M 57
ROCGU Roth CH Acquisition IV Co. $10.29 +2.90% $57.15M 57

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are ARGC's Key Strengths?

  • Diversified business model spanning dietary supplements and cannabis consulting.
  • Positive gross margin of 38.9% indicating efficient core operations.
  • Established in 2016, providing several years of operational history.
  • Positioned in growing markets: health/wellness and legal cannabis.

What Are ARGC's Weaknesses?

  • Significant negative profit margin of -393.5% indicating substantial losses.
  • Small market capitalization of $19.07M, suggesting limited resources and market influence.
  • OTC Other listing, which typically entails lower liquidity and less stringent disclosure requirements.
  • Classification as a 'Shell Company' within Financial Services, which might obscure its operational identity.

What Could Drive ARGC Stock Higher?

  • Expansion of Cannabis Legalization: Further state-level legalization or federal policy shifts regarding cannabis could significantly increase the market for Arion Group Corp.'s cultivation consulting services, driving new client acquisition and revenue growth.
  • Growth in Nutritional Supplement Demand: Continued consumer focus on health and wellness is expected to fuel sustained demand for dietary ingredients and nutritional supplements, providing a stable revenue base for ARGC's manufacturing and distribution segment.
  • New Consulting Contracts: Securing significant new contracts for cannabis cultivation planning, design, or compliance could provide substantial revenue boosts and validate ARGC's expertise in this specialized field.
  • Operational Efficiency Improvements: Initiatives aimed at improving operational efficiency in its manufacturing and distribution processes could lead to better cost management and a reduction in the company's negative profit margin, enhancing financial performance.

What Are the Key Risks for ARGC?

  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
  • Significant Negative Profit Margin: The reported profit margin of -393.5% indicates substantial ongoing losses, raising concerns about the company's long-term financial viability and ability to fund operations without external capital.
  • Regulatory Uncertainty in Cannabis Industry: The cannabis sector is subject to evolving and often unpredictable regulatory changes at both state and federal levels, which could impact the demand or legality of ARGC's consulting services.
  • Intense Competition: Both the dietary supplement and cannabis consulting markets are highly competitive, potentially limiting ARGC's pricing power, market share growth, and overall profitability.
  • OTC Market Risks: Trading on the 'OTC Other' tier exposes investors to risks of low liquidity, high volatility, and limited public disclosure, making it challenging to assess and trade the stock effectively.
  • Dependence on Key Personnel: Given the specialized nature of its consulting services, the company may be highly dependent on the expertise and relationships of key management or consultants, posing a risk if these individuals depart.

What Are the Growth Opportunities for ARGC?

  • Expansion within the U.S. Dietary Ingredient and Nutritional Supplement Market: The U.S. market for dietary supplements continues to demonstrate robust growth, driven by increasing consumer awareness of health and wellness, an aging population, and a proactive approach to preventative health. Arion Group Corp. has an opportunity to expand its manufacturing and distribution footprint by introducing new product lines, enhancing its supply chain efficiencies, and securing additional retail partnerships. The global dietary supplements market size was valued at over $160 billion in 2023 and is projected to grow at a CAGR of approximately 9% through 2030. By capturing a larger share of this expanding market, ARGC could significantly bolster its revenue streams within the next 3-5 years.
  • Increased Demand for Cannabis Cultivation Consulting Services: As more U.S. states move towards the legalization of medical and recreational cannabis, the demand for expert consulting in cultivation planning, design, and regulatory compliance is expected to surge. Arion Group Corp.'s established services in this niche position it to capitalize on new market entrants and expanding operations. The U.S. legal cannabis market is projected to reach over $70 billion by 2030, with significant investment in cultivation infrastructure. By enhancing its service offerings and marketing its compliance expertise, ARGC can secure a greater number of high-value consulting contracts, particularly in states with newly established or evolving regulatory frameworks over the next 2-4 years.
  • Strategic Partnerships and Acquisitions in Complementary Sectors: To accelerate growth and expand market reach, Arion Group Corp. could pursue strategic partnerships or targeted acquisitions within either the dietary supplement or cannabis consulting industries. Collaborating with established brands or acquiring smaller, specialized firms could provide access to new customer bases, proprietary technologies, or enhanced distribution networks. For instance, a partnership with a large-scale supplement retailer or a cannabis technology provider could unlock significant synergies. Such initiatives, potentially unfolding over the next 3-6 years, could provide ARGC with a competitive edge and diversify its revenue sources, mitigating risks associated with reliance on organic growth alone.
  • Diversification of Cannabis Consulting Offerings: Beyond cultivation planning and compliance, Arion Group Corp. could expand its cannabis consulting services to include other high-demand areas such as market entry strategies, operational efficiency improvements, or even intellectual property and branding for cannabis products. As the industry matures, businesses will seek more sophisticated support services. By broadening its consulting portfolio, ARGC can cater to a wider range of clients and capture additional revenue streams from existing relationships. This diversification, implementable within the next 1-3 years, would leverage its existing expertise and client trust, positioning it as a more comprehensive solution provider in the cannabis ecosystem.
  • Leveraging E-commerce and Direct-to-Consumer Channels for Supplements: While the company focuses on manufacturing and distribution, a significant growth opportunity lies in directly engaging consumers through robust e-commerce platforms for its nutritional supplement products. The online retail segment for health and wellness products has seen exponential growth, accelerated by shifts in consumer purchasing habits. By investing in a strong digital presence, online marketing, and efficient direct-to-consumer logistics, Arion Group Corp. can bypass traditional distribution layers, potentially improving margins and gaining direct customer insights. This strategic shift, a medium-term opportunity over the next 2-5 years, could open up a vast, scalable market and build brand loyalty directly with end-users.

What Opportunities Does ARGC Have?

  • Expanding U.S. market for nutritional supplements driven by health consciousness.
  • Growth in demand for cannabis cultivation consulting due to ongoing legalization and industry maturation.
  • Potential for strategic partnerships or acquisitions to expand market reach and capabilities.
  • Leveraging e-commerce to directly reach consumers in the nutritional supplement market.

What Threats Does ARGC Face?

  • Intense competition in both the dietary supplement and cannabis consulting sectors.
  • Regulatory changes and uncertainties in the cannabis industry could impact consulting demand.
  • Economic downturns potentially affecting consumer spending on discretionary health products.
  • Risks associated with OTC trading, including price volatility and difficulty in share liquidation.

What Are ARGC's Competitive Advantages?

  • Specialized expertise in cannabis cultivation planning, design, and regulatory compliance, a complex and evolving field.
  • Established manufacturing and distribution capabilities within the U.S. dietary ingredient and nutritional supplement market.
  • Dual business model potentially diversifying revenue streams and reducing reliance on a single industry.
  • Operational base in California, a key state for both nutritional supplements and cannabis industry developments.

What Does ARGC Do?

Arion Group Corp. (ARGC), established in 2016 and headquartered in City of Industry, California, operates with a distinctive dual business focus within the United States. The company's primary activities involve the manufacturing and distribution of dietary ingredients and nutritional supplements. This segment addresses the growing consumer demand for health and wellness products, encompassing a range of ingredients and finished goods designed to support various aspects of human health. ARGC aims to leverage its operational capabilities to serve the expansive U.S. market for these products, contributing to the supply chain from raw material processing to final product delivery. Beyond its involvement in the health and wellness sector, Arion Group Corp. extends its expertise into the burgeoning cannabis industry. The company provides specialized consulting services to third parties, assisting them with the intricate processes involved in cannabis cultivation. These services are comprehensive, covering critical areas such as initial planning, facility design, and ensuring full compliance with the evolving regulatory frameworks governing cannabis operations. This dual operational strategy positions ARGC to potentially capitalize on distinct market trends: the steady demand in the nutritional supplement space and the dynamic, growth-oriented landscape of regulated cannabis. The company's base in City of Industry, California, places it within a region known for both its manufacturing infrastructure and its proximity to key markets and regulatory developments, particularly concerning the cannabis industry in California.

What Products and Services Does ARGC Offer?

  • Manufactures dietary ingredients for the health and wellness industry.
  • Distributes nutritional supplements across the United States.
  • Provides consulting services for cannabis cultivation planning to third-party clients.
  • Offers expert guidance on the design of cannabis cultivation facilities.
  • Assists clients with ensuring compliance with cannabis cultivation regulations.
  • Operates from its base in City of Industry, California, serving U.S. markets.

How Does ARGC Make Money?

  • Generates revenue through the sale of manufactured dietary ingredients to various clients.
  • Earns income from the distribution of nutritional supplements to retailers and potentially other channels.
  • Receives fees for providing specialized consulting services related to cannabis cultivation planning and design.
  • Secures revenue from compliance consulting services, guiding third parties through complex cannabis regulations.

What Industry Does ARGC Operate In?

Arion Group Corp. is classified within the Financial Services sector under the 'Shell Companies' industry, an unusual categorization given its operational focus on dietary ingredient manufacturing, nutritional supplement distribution, and cannabis cultivation consulting. This classification suggests that its primary financial structure or public listing mechanism aligns with a shell entity, even as it conducts tangible business operations. The dietary supplement market is characterized by consistent consumer demand for health and wellness products, driven by demographic shifts and increasing health consciousness. The cannabis industry, particularly consulting for cultivation, is a rapidly evolving segment influenced by ongoing regulatory changes and expanding legalization across U.S. states. ARGC's positioning allows it to potentially tap into growth in both these distinct markets, though its 'Shell Companies' classification might influence investor perception and regulatory scrutiny. The competitive landscape in both sectors is fragmented, with numerous specialized players, requiring ARGC to differentiate through expertise in compliance for cannabis and efficient distribution for supplements.

Who Are ARGC's Key Customers?

  • Retailers and distributors in the nutritional supplement market across the U.S.
  • Third-party entities seeking expertise in establishing or optimizing cannabis cultivation operations.
  • Businesses requiring guidance on regulatory compliance within the evolving cannabis industry.
  • Potentially other manufacturers or brands sourcing dietary ingredients.
AI Confidence: 68% Updated: Jun 13, 2026

How Arion Group Corp. Is Valued

Arion Group Corp. carries a market capitalization of $19.07M, placing it in the micro-cap category. Relative to its peer group, ARGC's quantitative score of 45/100 is below the peer average of 65/100.

Company Profile

Arion Group Corp. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in City Of Industry, US. The company is led by CEO Jay Hamilton. ARGC has traded publicly since 2018.

ROE 44%Key Financial Metrics

Return on equity for Arion Group Corp. stands at 44.3%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -0.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.13 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -0.4%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 3/9Financial Health

Arion Group Corp.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 22.78 places it in the safe zone, indicating low near-term bankruptcy risk.

ARGC Financials

Fundamental Snapshot

Return on Equity (TTM)
+44.3%
Current Ratio
0.1

Based on FMP financials and quantitative analysis

Bull Case vs Bear Case

Bull Case

  • Diversified business model spanning dietary supplements and cannabis consulting.
  • Positive gross margin of 38.9% indicating efficient core operations.
  • Established in 2016, providing several years of operational history.
  • Positioned in growing markets: health/wellness and legal cannabis.

Bear Case

  • Significant negative profit margin of -393.5% indicating substantial losses.
  • Small market capitalization of $19.07M, suggesting limited resources and market influence.
  • OTC Other listing, which typically entails lower liquidity and less stringent disclosure requirements.
  • Classification as a 'Shell Company' within Financial Services, which might obscure its operational identity.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026

ARGC Latest News

No recent news available for ARGC.

ARGC Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ARGC.

Price Targets

Wall Street price target analysis for ARGC.

ARGC MoonshotScore

45/100

What does this score mean?

The MoonshotScore rates ARGC's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Jay Hamilton

Chief Executive Officer

Jay Hamilton serves as the Chief Executive Officer of Arion Group Corp. Details regarding his specific career history, educational background, and previous roles prior to leading Arion Group Corp. are not publicly available in the provided source data. His leadership is central to guiding the company's dual operational strategy in dietary ingredients/nutritional supplements and cannabis cultivation consulting. Further information on his professional journey, including any prior executive positions or industry-specific credentials, is unknown.

Track Record: Specific achievements, strategic decisions, or company milestones directly attributable to Jay Hamilton's leadership at Arion Group Corp. are not detailed in the provided information. His tenure has overseen the company's focus on manufacturing and distribution within the dietary supplement industry, alongside the development of its cannabis cultivation consulting services. The company's current financial metrics, including its gross margin and profit margin, reflect the operational landscape under his direction. Further specifics on his track record are unknown.

ARGC OTC Market Information

Arion Group Corp. trades on the OTC market under the 'OTC Other' tier. This classification signifies that the company does not meet the disclosure requirements for OTCQX or OTCQB, nor does it qualify for the Pink Open Market tier. Companies in the 'OTC Other' category typically have limited public disclosure, which can make it challenging for investors to access comprehensive financial and operational information. Unlike stocks listed on major exchanges like NYSE or NASDAQ, which adhere to stringent listing standards including minimum share prices, market capitalization, and regular SEC filings, 'OTC Other' companies operate with significantly less oversight and transparency. This tier is often associated with smaller, less liquid companies or those with distressed financials.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Given Arion Group Corp.'s small market capitalization of $19.07M and its 'OTC Other' classification, liquidity is likely to be very low. Trading volume may be sporadic, leading to wide bid-ask spreads, which can make it difficult for investors to buy or sell shares at desired prices. The limited number of shares traded daily means that even small transactions can significantly impact the stock price. This illiquidity poses a substantial challenge for institutional investors requiring efficient entry and exit points, and it increases the risk of price manipulation.
OTC Risk Factors:
  • Limited Public Information: The 'OTC Other' tier implies minimal disclosure, making it difficult for investors to conduct thorough due diligence and assess the company's financial health and operational performance.
  • Low Liquidity: Small trading volumes and wide bid-ask spreads can make it challenging to buy or sell shares, potentially leading to significant price slippage.
  • Price Volatility: Due to low liquidity and limited information, ARGC's stock price may experience extreme volatility, making it susceptible to rapid and unpredictable fluctuations.
  • Lack of Regulatory Oversight: Compared to major exchanges, OTC markets have less stringent regulatory requirements, which can expose investors to higher risks of fraud or manipulation.
  • Difficulty in Valuation: The absence of comprehensive financial data and analyst coverage makes it extremely challenging to accurately value the company's shares.
Due Diligence Checklist:
  • Verify the company's current operational status and actual business activities beyond its 'Shell Companies' classification.
  • Seek out any available financial statements or disclosures, even if limited, to assess revenue, expenses, and asset base.
  • Investigate the backgrounds and track records of management, particularly given the limited public information.
  • Research the competitive landscape and market trends in both the dietary supplement and cannabis consulting sectors.
  • Assess the company's capital structure, outstanding shares, and any recent financing activities.
  • Understand the regulatory environment for cannabis consulting services in the states where ARGC operates.
  • Evaluate the company's ability to generate sustainable revenue and improve its negative profit margin.
Legitimacy Signals:
  • The company was incorporated in 2016, indicating several years of existence, which is longer than many transient shell companies.
  • It explicitly states its operational focus on manufacturing and distribution in dietary ingredients/nutritional supplements and cannabis consulting services, suggesting active business endeavors.
  • Headquartered in City of Industry, California, a known commercial hub, provides a physical and established base of operations.
  • The presence of a named CEO, Jay Hamilton, provides a specific point of contact for leadership, even if detailed background is not available.

Arion Group Corp. Financial Services Stock: Key Questions Answered

What does Arion Group Corp. do?

Arion Group Corp. operates a dual business model from its base in City of Industry, California. Primarily, it is involved in the manufacturing and distribution of dietary ingredients and nutritional supplements across the United States, catering to the health and wellness market. Concurrently, the company provides specialized consulting services to third parties within the cannabis industry. These services encompass critical aspects of cannabis cultivation, including comprehensive planning, facility design, and ensuring strict compliance with the complex and evolving regulatory frameworks. This strategic positioning allows ARGC to engage with two distinct, yet potentially growing, market segments.

How does Arion Group Corp. generate revenue across its diverse operations?

Arion Group Corp. generates revenue through two primary channels corresponding to its dual business model. In the dietary ingredient and nutritional supplement segment, the company earns income from the direct sale of manufactured ingredients and the distribution of finished nutritional supplement products to various clients, including retailers and other businesses within the U.S. health sector. For its cannabis-related operations, revenue is derived from fees charged for its consulting services. These fees are typically structured for comprehensive assistance in cannabis cultivation, covering planning, design, and crucial regulatory compliance, provided to third-party clients seeking expertise in this specialized and regulated industry.

What are the implications of Arion Group Corp.'s OTC Other classification for investors?

Arion Group Corp.'s classification on the 'OTC Other' tier of the OTC market carries several significant implications for investors. This tier is characterized by minimal public disclosure requirements, meaning investors may have limited access to comprehensive financial statements, operational updates, or other critical information necessary for informed decision-making. Consequently, the stock is likely to experience low liquidity, resulting in wide bid-ask spreads and potential difficulty in executing trades at desired prices. The lack of stringent regulatory oversight compared to major exchanges also exposes investors to higher risks of price volatility and potential manipulation, making it a higher-risk investment category that demands extensive independent due diligence.

Given Arion Group Corp.'s negative profit margin, how does the company sustain operations?

Arion Group Corp.'s reported profit margin of -393.5% indicates that the company is currently incurring substantial losses relative to its revenue. While the company maintains a positive gross margin of 38.9%, suggesting that its core manufacturing and distribution activities are profitable before operating expenses, the significant negative profit margin implies that overhead, administrative costs, interest expenses, or other non-operating factors are consuming a disproportionate amount of revenue. To sustain operations under such conditions, the company would typically rely on existing cash reserves, secure additional financing through debt or equity issuance, or implement aggressive cost-cutting measures. Without further financial details, the exact mechanism of sustainability remains unclear, but it highlights a critical area for investor scrutiny regarding capital management and path to profitability.

What are the key factors to evaluate for ARGC?

Arion Group Corp. (ARGC) holds an AI score of 45/100 (low). Not financial advice.

How frequently does ARGC data refresh on this page?

ARGC prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven ARGC's recent stock price performance?

Arion Group Corp. (ARGC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified business model spanning dietary supplements and cannabis consulting. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider ARGC overvalued or undervalued right now?

Valuing Arion Group Corp. (ARGC) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • The 'Shell Companies' industry classification within 'Financial Services' sector for a company describing operational activities in dietary supplements and cannabis consulting is noted as potentially incongruous but strictly adhered to based on provided data.
  • CEO background and track record are marked as 'Unknown' due to lack of specific details in the source data beyond the name.
  • Competitors are marked as 'Unknown' as no FMP PEER TICKERS were provided.
  • Disclosure status for OTC is 'Unknown' as per source data.
Data Sources

Popular Stocks